View all conferences
May 23, 2023

US East Coast-Immuno-Oncology Xchange

Alloplex CEO, Dr. Borriello to attend and participate in round table discussions in the ‘new cellular modalities’ track.

Topics:

  1. SUPLEXA therapeutic cells
  2. Recently identified pharmacodynamic signature of activity

https://www.hub-xchange.com/immuno-oncology-xchange-east-coast-2023/ – Boston, MA.